This study analyzes the relations between doses administrated of vaccines for Coronavirus disease-2019 (COVID-19) and confirmed cases from March to May 2021 to find out the optimal level of doses administrated per 100 inhabitants, which can lead to a reduction in the diffusion of COVID-19 cases. Findings reveal that a delay of vaccination in population, it moves up the optimal value of doses administrated per 100 inhabitants from 58.5 to more than 86 per 100 people, with consequential damages and long-run deterioration of socioeconomic systems. This study suggests that the optimal policy to pandemic threats is the early, rapid, nationally vaccination rollout for an effective reduction of the spread of infectious disease that reduces negati...
A novel statistical model based on a two-layer, contact and information, graph is suggested in order...
Immediately after the start of the COVID-19 pandemic in Early 2020, most affected countries reacted ...
Since December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spre...
This study analyzes the relations between doses administrated of vaccines for Coronavirus disease-20...
This study analyses the relation between people fully vaccinated and mortality to assess the effecti...
This study investigates the impact of a national vaccination campaign on reducing severe disease ass...
The US and the rest of the world have suffered from the COVID-19 pandemic for over a year. The high ...
The global outbreak of COVID-19 caused by the SARS-CoV-2 virus elicited immense global interest in t...
The administration of vaccines against the coronavirus disease 2019 (COVID-19) started in early Dece...
Background: The increasing vaccination coverage against SARS-CoV-2 enabled relaxation of lockdowns i...
Governments worldwide are implementing mass vaccination programs in an effort to end the novel coron...
This paper uses large cross-country data for 110 countries to examine the effectiveness of COVID vac...
Vaccines are needed to protect from SARS-CoV-2, the virus causing COVID-19. Vaccines that induce lar...
Epidemics of infectious diseases have always been well documented throughout the human history, part...
One and a half years into the pandemic, SARS-CoV-2 is still here to stay. Whilst rapid several effec...
A novel statistical model based on a two-layer, contact and information, graph is suggested in order...
Immediately after the start of the COVID-19 pandemic in Early 2020, most affected countries reacted ...
Since December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spre...
This study analyzes the relations between doses administrated of vaccines for Coronavirus disease-20...
This study analyses the relation between people fully vaccinated and mortality to assess the effecti...
This study investigates the impact of a national vaccination campaign on reducing severe disease ass...
The US and the rest of the world have suffered from the COVID-19 pandemic for over a year. The high ...
The global outbreak of COVID-19 caused by the SARS-CoV-2 virus elicited immense global interest in t...
The administration of vaccines against the coronavirus disease 2019 (COVID-19) started in early Dece...
Background: The increasing vaccination coverage against SARS-CoV-2 enabled relaxation of lockdowns i...
Governments worldwide are implementing mass vaccination programs in an effort to end the novel coron...
This paper uses large cross-country data for 110 countries to examine the effectiveness of COVID vac...
Vaccines are needed to protect from SARS-CoV-2, the virus causing COVID-19. Vaccines that induce lar...
Epidemics of infectious diseases have always been well documented throughout the human history, part...
One and a half years into the pandemic, SARS-CoV-2 is still here to stay. Whilst rapid several effec...
A novel statistical model based on a two-layer, contact and information, graph is suggested in order...
Immediately after the start of the COVID-19 pandemic in Early 2020, most affected countries reacted ...
Since December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spre...